Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4475661
Max Phase: Preclinical
Molecular Formula: C14H10N4O5S
Molecular Weight: 346.32
Molecule Type: Unknown
Associated Items:
ID: ALA4475661
Max Phase: Preclinical
Molecular Formula: C14H10N4O5S
Molecular Weight: 346.32
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Cc1nc2c([N+](=O)[O-])csc2c(=O)n1Cc1ccc([N+](=O)[O-])cc1
Standard InChI: InChI=1S/C14H10N4O5S/c1-8-15-12-11(18(22)23)7-24-13(12)14(19)16(8)6-9-2-4-10(5-3-9)17(20)21/h2-5,7H,6H2,1H3
Standard InChI Key: MOBIMOQMAVHBOX-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 346.32 | Molecular Weight (Monoisotopic): 346.0372 | AlogP: 2.63 | #Rotatable Bonds: 4 |
Polar Surface Area: 121.17 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 9 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 0.61 | CX LogP: 2.51 | CX LogD: 2.51 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.53 | Np Likeness Score: -1.72 |
1. Shao X, AbdelKhalek A, Abutaleb NS, Velagapudi UK, Yoganathan S, Seleem MN, Talele TT.. (2019) Chemical Space Exploration around Thieno[3,2-d]pyrimidin-4(3H)-one Scaffold Led to a Novel Class of Highly Active Clostridium difficile Inhibitors., 62 (21): [PMID:31584822] [10.1021/acs.jmedchem.9b01198] |
Source(1):